Heart Disease, Thyroid Disease, and Statins: New Links, New Solutions
It should be no secret that heart disease is inextricably linked to thyroid disease, especially hypothyroidism caused by such maladies as Hashimoto’s Thyroiditis (a condition I suffer from).
A recent study of 25,000 people recently published in the Archives of Internal Medicine has confirmed that sub-clinical hypothyroidism (those with supposedly normal TSH test results) is positively linked to fatal heart disease in women. However, there were not enough cardiac deaths to extend this conclusion to men (note that this DOES NOT mean men are not affected, it simply means there were not enough events to prove it statistically within the 95% confidence interval established for the study). This study confirms the findings of a smaller study published in the Archives last year.
The message these studies provide is clear. Persons with TSH test results even in the intermediate range of “normal” (1.14-2.52 mIU/L) may be at heightened risk for cardiac death. The practical result is that patients should no longer rely on supposedly “normal” TSH test results to rule out hypothyroidism.
Now come two new studies that suggest statins may help to control your heart and thyroid disease - even if you test normal for both cholesterol and thyroid levels.
The JUPITER study was recently terminated a year early because of overwhelming evidence that even individuals with LDL cholesterol well below established guidelines benefited from taking a statin if they had elevated C-reactive-protein (CRP) levels (CRP is a measure of inflammation - more on that later). Investigators showed that 20mg daily of rosuvastatin significantly reduced nonfatal MI (heart attack), nonfatal stroke, hospitalization for unstable angina, revascularization, and confirmed death from cardiovascular causes by 44% compared with individuals treated with placebo. Of course, we must take the study with a grain of salt since it was sponsored by the company that makes rosuvastatin but the results are impressive. The key here is that statins appear to also have powerful anti-infalmmatory effects.
Another study involved hyperthyroid patients taking various statins. The conlcusion reached was that "Statins may falsely lower the serum TSH without altering thyroid function (“pseudohyperthyroidism”) or, alternatively, statins may improve thyroid function in patients with hyperthyroidism. An earlier hypothyroidism study looking at simvastatin noted, "An increase in serum free tri-iodothyronine (T3) and free thyroxine (T4) levels and a decrease in TSH levels were observed (P < 0.05) with Simvastatin treatment. Similar to the JUPITER study, the effect suggested that, “Simvastatin is an immune modulatory agent and improves thyroid function in patients with HT” (Hashimoto’s Thyroiditis, a form of hypothyroidism) and in all likelihood the effect is, “not confined to Simvastatin since Mevastatin, Pravastatin and Cerivastatin also induced apoptosis in lymphocytes.”
The upshot of these studies that is one of the pleiotropic effects long thought to be associated with statins is a powerful anti-inflammatory effect even though the mechanism of action is not well understood. More intriguing is that this potential anti-inflammatory effect produces powerful benefits across several diseases and conditions that are linked such as heart disease and thyroid function.
Statins are powerful drugs to be sure and subsequently can have powerful unwanted side effects as well as beneficial effects. Every one of us will react slightly differently to virtually any medication. I take rosuvastatin and suffered through the muscle aches which subsided by lowering my dose (5mg every other day) and taking Co-Q10 (150mg day). Always consult your doctor before starting or changing any drug or supplement regimen. But like any good health consumer don’t simply follow the crowd. Keep your eyes open, do what research you can, weigh the risks and benefits, and work with your health professional to make the best for your personal health.
Looking out for your heart health,
Chris Kliesmet, also known as HeartHawk, is a heart health activist and former patient expert writer for HealthCentral. As a heart disease sufferer with many family members lost to the disease, Chris specialized in topics within heart health, including medication, prevention, and testing. He has written for other community sites such as HeartConnect.com, and wrote for his own blog, HEARTHAWK: Your Heart Health Eye in the Sky. (Photo: University of Wisconsin)